Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients.

Yen-Chun LiuYa-Ting ChengYi-Cheng ChenYi-Chung HsiehWen-Juei JengChun-Yen LinRong-Nan ChienDar-In TaiI-Shyan Sheen

Published in: Digestive diseases and sciences (2022)

ACLD patients who met advanced fibrosis but not cirrhosis by guidelines' cut-offs still posed high risk of HCC. Baseline LSM with SVR FIB-4 can be applied to stratify low, intermediate, and high risk of HCC for personalizing surveillance strategies after SVR.

Keyphrases

newly diagnosed
end stage renal disease
ejection fraction
liver fibrosis
public health
prognostic factors
clinical practice
patient reported outcomes